Characterization of Urinary N-Acetyltaurine as a Biomarker of Hyperacetatemia in Mice

Qingqing Mao,Xiaolei Shi,Yiwei Ma,Yuwei Lu,Chi Chen

DOI: https://doi.org/10.3390/metabo14060322

IF: 4.1

2024-06-08

Metabolites

Abstract:Acetate is an important metabolite in metabolic fluxes. Its presence in biological entities originates from both exogenous inputs and endogenous metabolism. Because the change in blood acetate level has been associated with both beneficial and adverse health outcomes, blood acetate analysis has been used to monitor the systemic status of acetate turnover. The present study examined the use of urinary N-acetyltaurine (NAT) as a marker to reflect the hyperacetatemic status of mice from exogenous inputs and endogenous metabolism, including triacetin dosing, ethanol dosing, and streptozotocin-induced diabetes. The results showed that triacetin dosing increased serum acetate and urinary NAT but not other N-acetylated amino acids in urine. The co-occurrences of increased serum acetate and elevated urinary NAT were also observed in both ethanol dosing and streptozotocin-induced diabetes. Furthermore, the renal cortex was determined as an active site for NAT synthesis. Overall, urinary NAT behaved as an effective marker of hyperacetatemia in three experimental mouse models, warranting further investigation into its application in humans.

biochemistry & molecular biology

What problem does this paper attempt to address?

The main problem that this paper attempts to solve is to evaluate the effectiveness of N - acetyl taurine (NAT) in urine as a biomarker for hyperacetatemia in mice. Specifically, the researchers explored this problem in the following ways:

1. **Direct acetate intake**: By orally administering triacetin to mice, which is a triglyceride containing three acetate units, the acetate level in the mice can be rapidly increased. The study found that triacetin treatment significantly increased the acetate concentration in the serum, and the NAT concentration in the urine also increased significantly, but other N - acetylated amino acids (such as N - acetyl glutamate, N - acetyl glutamine, etc.) did not change significantly.

2. **Indirect acetate input**: By feeding mice with ethanol, because acetate is the main intermediate product of alcohol metabolism. The results showed that ethanol feeding increased the acetate concentration in the serum and also increased the excretion of NAT in the urine.

3. **Endogenous acetate production**: The effect of endogenous acetate production was studied through a streptozotocin (STZ) - induced mouse diabetes model. STZ - induced diabetes led to hyperglycemia, and both the acetate concentration in the serum and the NAT concentration in the urine increased significantly. In addition, although taurine supplementation increased the taurine concentration in the serum, it had no effect on the changes in serum acetate and urine NAT caused by STZ.

4. **NAT synthesis site**: To determine the NAT synthesis site in the kidney, the researchers used bovine kidney tissue for in vitro experiments and compared the NAT synthesis activities in renal cortex and renal medulla samples. The results showed that the renal cortex is the main site of NAT synthesis.

In conclusion, this study verified the effectiveness of NAT in urine as a biomarker for hyperacetatemia through multiple experimental models and provided a theoretical basis for its further application in human health monitoring.